HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers
Phase of Trial: Phase II
Latest Information Update: 25 May 2015
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Therapeutic Use
- 06 Sep 2011 Planned end date changed from 1 Mar 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 06 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Jun 2008 New trial record.